Residual Weighted Learning for Estimating Individualized Treatment Rules

TL;DR

This paper introduces Residual Weighted Learning (RWL), a novel method for estimating individualized treatment rules that improves upon outcome weighted learning by using residuals, accommodating various outcome types, and incorporating variable selection.

Contribution

The paper proposes RWL, a new framework that enhances ITR estimation by weighting residuals, utilizing a convex optimization algorithm, and enabling variable selection for different outcome types.

Findings

RWL outperforms OWL in finite sample scenarios.

The method effectively handles continuous, binary, and count outcomes.

Simulation and clinical data demonstrate RWL's superior performance.

Abstract

Personalized medicine has received increasing attention among statisticians, computer scientists, and clinical practitioners. A major component of personalized medicine is the estimation of individualized treatment rules (ITRs). Recently, Zhao et al. (2012) proposed outcome weighted learning (OWL) to construct ITRs that directly optimize the clinical outcome. Although OWL opens the door to introducing machine learning techniques to optimal treatment regimes, it still has some problems in performance. In this article, we propose a general framework, called Residual Weighted Learning (RWL), to improve finite sample performance. Unlike OWL which weights misclassification errors by clinical outcomes, RWL weights these errors by residuals of the outcome from a regression fit on clinical covariates excluding treatment assignment. We utilize the smoothed ramp loss function in RWL, and provide a difference of convex (d.c.) algorithm to solve the corresponding non-convex optimization problem. By estimating residuals with linear models or generalized linear models, RWL can effectively deal with different types of outcomes, such as continuous, binary and count outcomes. We also propose variable selection methods for linear and nonlinear rules, respectively, to further improve the performance. We show that the resulting estimator of the treatment rule is consistent. We further obtain a rate of convergence for the difference between the expected outcome using the estimated ITR and that of the optimal treatment rule. The performance of the proposed RWL methods is illustrated in simulation studies and in an analysis of cystic fibrosis clinical trial data.